argenx to buy Unnatural Products for up to BioPharm International · · AI-summarised by FinFlash
Belgian biotech argenx agreed to acquire Santa Cruz-based Unnatural Products, a macrocyclic peptide discovery company, for up to about So What?
The bolt-on adds an oral peptide platform to argenx's immunology pipeline with limited balance sheet strain. Watch for disclosure of specific programs and targets.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
BioPharm International · · AI-summarised by FinFlash
Belgian biotech argenx agreed to acquire Santa Cruz-based Unnatural Products, a macrocyclic peptide discovery company, for up to about The bolt-on adds an oral peptide platform to argenx's immunology pipeline with limited balance sheet strain. Watch for disclosure of specific programs and targets. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context